Aequus Pharmaceuticals Valuation
| AQSZF Stock | USD 0.01 0 18.18% |
Aequus Pharmaceuticals seems to be fairly valued based on Macroaxis valuation methodology. Our model approximates the value of Aequus Pharmaceuticals from analyzing the firm fundamentals such as Return On Equity of -2.92, current valuation of 3.03 M, and Profit Margin of (1.36) % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Aequus Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Aequus Pharmaceuticals is based on 3 months time horizon. Increasing Aequus Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aequus otc stock is determined by what a typical buyer is willing to pay for full or partial control of Aequus Pharmaceuticals. Since Aequus Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aequus OTC Stock. However, Aequus Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0065 | Real 0.00624 | Hype 0.008093 |
The real value of Aequus OTC Stock, also known as its intrinsic value, is the underlying worth of Aequus Pharmaceuticals OTC Stock, which is reflected in its stock price. It is based on Aequus Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aequus Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Aequus Pharmaceuticals helps investors to forecast how Aequus otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aequus Pharmaceuticals more accurately as focusing exclusively on Aequus Pharmaceuticals' fundamentals will not take into account other important factors: Aequus Pharmaceuticals Total Value Analysis
Aequus Pharmaceuticals is presently forecasted to have takeover price of 3.03 M with market capitalization of 4.12 M, debt of 26.09 K, and cash on hands of 1.39 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aequus Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.03 M | 4.12 M | 26.09 K | 1.39 M |
Aequus Pharmaceuticals Investor Information
About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Aequus Pharmaceuticals had not issued any dividends in recent years. Based on the key indicators related to Aequus Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Aequus Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Aequus Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aequus Pharmaceuticals has an asset utilization ratio of 62.43 percent. This implies that the OTC Stock is making $0.62 for each dollar of assets. An increasing asset utilization means that Aequus Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Aequus Pharmaceuticals Ownership Allocation
Aequus Pharmaceuticals holds a total of 132.63 Million outstanding shares. Aequus Pharmaceuticals shows 14.96 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Aequus Pharmaceuticals Profitability Analysis
The company reported the revenue of 2.71 M. Net Loss for the year was (1.81 M) with profit before overhead, payroll, taxes, and interest of 2.69 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aequus Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aequus Pharmaceuticals and how it compares across the competition.
About Aequus Pharmaceuticals Valuation
The otc valuation mechanism determines Aequus Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Aequus Pharmaceuticals. We calculate exposure to Aequus Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aequus Pharmaceuticals's related companies.Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Aequus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 14 people.
8 Steps to conduct Aequus Pharmaceuticals' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Aequus Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Aequus Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Aequus Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Aequus Pharmaceuticals' revenue streams: Identify Aequus Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Aequus Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Aequus Pharmaceuticals' growth potential: Evaluate Aequus Pharmaceuticals' management, business model, and growth potential.
- Determine Aequus Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Aequus Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Aequus Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Aequus Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 132.6 M | |
| Retained Earnings | -26.5 M |
Complementary Tools for Aequus OTC Stock analysis
When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |